Brevan Howard Capital Management’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585K Buy
+2,677
New +$579K ﹤0.01% 1369
2026
Q1
– Sell
-10,231
Closed -$1.34M – 2458
2025
Q4
$1.34M Sell
10,231
-4,518
-31% -$594K 0.01% 644
2025
Q3
$1.93M Buy
14,749
+5,329
+57% +$726K 0.01% 579
2025
Q2
$1.39M Buy
+9,420
New +$1.11M 0.01% 911
2024
Q1
– Sell
-4,646
Closed -$615K – 1325
2023
Q4
$615K Buy
+4,646
New +$508K 0.01% 398

Other funds holding SLAB

Brevan Howard Capital Management's SLAB Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Silicon Laboratories (SLAB) in Q2 2026: 2,677 shares worth $585K. The stake represents ﹤0.01% of the portfolio and ranks #1369 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in SLAB as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in SLAB in Q4 2023 and has held it in 5 quarters since. The position peaked at $1.93M in Q3 2025. 354 funds tracked by Wall St. Rank hold SLAB as of Q2 2026.

  • Brevan Howard Capital Management held 2,677 shares of Silicon Laboratories worth $585K as of Q2 2026.
  • Silicon Laboratories was a new Brevan Howard Capital Management position in Q2 2026.
  • Silicon Laboratories made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1369 holding.
  • Brevan Howard Capital Management first reported a position in Silicon Laboratories in Q4 2023 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's Silicon Laboratories position peaked at $1.93M in Q3 2025.
  • 354 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.